Comparison of resistance against erythromycin and moxifloxacin, presence of binary toxin gene and PCR ribotypes in Clostridium difficile isolates from 1990 and 2008

被引:10
作者
Ilchmann, C. [1 ]
Zaiss, N. H. [2 ]
Speicher, A. [1 ]
Christner, M. [1 ]
Ackermann, G. [3 ]
Rohde, H. [1 ]
机构
[1] Univ Klinikum Hamburg Eppendorf, Inst Med Mikrobiol Virol & Hyg, D-20246 Hamburg, Germany
[2] Robert Koch Inst, D-38855 Wernigerode, Germany
[3] MVZ Lab Diagnost & Med Mikrobiol Dr Ackermann Gmb, D-04317 Leipzig, Germany
关键词
INFECTION; EPIDEMIC; EUROPE;
D O I
10.1007/s10096-010-1017-9
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Worldwide increasing rates of Clostridium difficile infections (CDI) with severe courses and outbreaks have been reported. This change in CDI epidemiology has on one hand been related to the spread of specific PCR ribotypes (e.g. 027) and on the other hand to increased prevalence of resistant C. difficile strains. This single-centre retrospective analysis characterized resistance against erythromycin and moxifloxacin, presence of binary toxin gene and ribotypes in 73 C. difficile isolates from 2008 in comparison with 23 isolates from 1990. In 1990, five different PCR ribotypes including 027 were identified. Resistance against erythromycin was detected in 3 of 23 (13%), while 20 of 23 (87%) from all isolates were susceptible to both erythromycin and moxifloxacin. In contrast, in 2008 a significantly increased prevalence of resistant C. difficile strains was observed, with 40 of 73 (54.8%) isolates being resistant against both antibiotics. Resistant C. difficile strains were mainly assigned to PCR ribotype 001. No isolates belonging to PCR ribotype 027 were identified. Our data provide evidence that the increase of resistant C. difficile strains belonging to PCR ribotype 001 rather than the spread of C. difficile PCR ribotype 027 contribute to the changing epidemiology of CDI.
引用
收藏
页码:1571 / 1573
页数:3
相关论文
共 11 条
[1]  
Arvand M, 2009, EUROSURVEILLANCE, V14, P27
[2]   Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates [J].
Barbut, F. ;
Mastrantonio, P. ;
Delmee, M. ;
Brazier, J. ;
Kuijper, E. ;
Poxton, I. .
CLINICAL MICROBIOLOGY AND INFECTION, 2007, 13 (11) :1048-1057
[3]   Development of a new PCR-ribotyping method for Clostridium difficile based on ribosomal RNA gene sequencing [J].
Bidet, P ;
Barbut, F ;
Lalande, V ;
Burghoffer, B ;
Petit, JC .
FEMS MICROBIOLOGY LETTERS, 1999, 175 (02) :261-266
[4]  
Borgmann S, 2008, Euro Surveill, V13
[5]   What is the role of antimicrobial resistance in the new epidemic of Clostridium difficile? [J].
Coia, John E. .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2009, 33 :S9-S12
[6]   Efficacy of hospital cleaning agents and germicides against epidemic Clostridium difficile strains [J].
Fawley, Warren N. ;
Underwood, Sarah ;
Freeman, Jane ;
Baines, Simon D. ;
Saxton, Katie ;
Stephenson, Keith ;
Owens, Robert C., Jr. ;
Wilcox, Mark H. .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2007, 28 (08) :920-925
[7]   Outbreak of Clostridium difficile infection in a long-term care facility:: Association with gatifloxacin use [J].
Gaynes, R ;
Rimland, D ;
Killum, E ;
Lowery, HK ;
Johnson, TM ;
Killgore, G ;
Tenover, FC .
CLINICAL INFECTIOUS DISEASES, 2004, 38 (05) :640-645
[8]   Emergence of Clostridium difficile-associated disease in North America and Europe [J].
Kuijper, E. J. ;
Coignard, B. ;
Tull, P. .
CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 :2-18
[9]   An epidemic, toxin gene-variant strain of Clostridium difficile [J].
McDonald, LC ;
Killgore, GE ;
Thompson, A ;
Owens, RC ;
Kazakova, SV ;
Sambol, SP ;
Johnson, S ;
Gerding, DN .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (23) :2433-2441
[10]   Clostridium difficile toxinotype V, Ribotype 078, in animals and humans [J].
Rupnik, Maja ;
Widmer, Andreas ;
Zimmermann, Ortrud ;
Eckert, Catherine ;
Barbut, Frederic .
JOURNAL OF CLINICAL MICROBIOLOGY, 2008, 46 (06) :2146-2146